Background: The need for breed-specific reference intervals (RIs) for Greyhounds has been identified. As Lurchers are a sighthound cross-breed, specific RIs may also be needed for these dogs. Hematologic RIs for Greyhounds and Lurchers using the Sysmex XT-2000iV hematology analyzer have not been established.
Objectives: The aims of this study were to establish RIs for Greyhounds using the Sysmex XT-2000iV, to investigate whether RIs for Greyhound and nonsighthound dogs could be transferred to Lurchers, and to establish new RIs for Lurchers if transference was not possible.
Methods: Data were retrieved retrospectively from a database of blood donor dogs. Greyhound RIs were established using nonparametric methods based on a reference population of 179 dogs. For the RI transference study, 38 Lurchers were selected, following guidelines proposed by the Clinical and Laboratory Standards Institute. When transference was not appropriate, new RIs were generated using the robust method.
Results: Greyhound RIs for the Sysmex hematology analyzer reflected known differences in this breed with a tendency toward higher RBC mass and lower WBC and platelet counts. RIs for hemoglobin concentration, HCT, MCV, MCH, MCHC, and WBC, neutrophil, lymphocyte, monocyte, and platelet counts for Greyhounds were suitable for transference to Lurchers. For RBC and eosinophil counts, new RIs were established.
Conclusion: Our study suggests that Lurchers share many hematologic characteristics with Greyhounds, but had higher reference limits for RBC and eosinophil counts.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1939-165X.2011.00356.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Validation of the Sysmex XN-V hematology analyzer for feline specimens.
Vet Clin Pathol
September 2024
Département des Sciences Cliniques des Animaux de Compagnie et de Sport, Université de Toulouse, ENVT, Toulouse, France.
Background: The Sysmex XN-V is derived from the new Sysmex XN series of human hematology analyzers. The main changes from the previously validated XT-2000iV analyzer include an optic-fluorescent analysis for platelets and a nucleated red blood cell (NRBC) count.
Objective: We aimed to validate the Sysmex XN-V for feline blood following the American College for Veterinary Clinical Pathology and International Council for Standardization in Hematology recommendations.
Repeat patient testing-quality control compared to commercial quality control material for the Sysmex XT-2000iV hematology analyzer in a multi-site veterinary laboratory.
Vet Clin Pathol
February 2024
Veterinary Information Network, Davis, California, USA.
Background: Quality control material (QCM) for hematology in veterinary laboratories is limited, and repeat patient testing quality control (RPT-QC) is an alternative method using excess matrix-specific samples.
Objectives: This study aimed to determine if median differences between RPT-QC analyses for each time interval for RBC, HGB, HCT, and WBC were the same, determine if unified RPT-QC limits can be applied to a network of veterinary laboratories, compare the performance of RPT-QC to commercial QCM for the reference analyzer and evaluate the experience over a 4 month period and design, improve and implement an automated spreadsheet for RPT-QC data management.
Methods: The potential to unify individual analyzer RPT-QC limits for red blood cells (RBC), hematocrit (HCT), hemoglobin (HGB), and white blood cells (WBC) on multi-site Sysmex XT-2000-iV analyzers was explored by a difference of means test and confidence interval determination for the median difference for each network analyzer in comparison to the network reference analyzer.
Repeat patient testing-quality control with canine samples shows promise as an alternative to commercial quality control material for a network of four Sysmex XT-2000iV hematology analyzers.
Vet Clin Pathol
February 2024
SYNLAB-VPG/Exeter, Exeter, UK.
Background: Repeat patient testing-quality control (RPT-QC) uses retained patient samples as an alternative to commercial quality control material (QCM). We elected to calculate and validate RPT-QC limits for red blood cell count (RBC), hemoglobin (HBG), hematocrit (HCT), and white blood cell count (WBC).
Objectives: (1) To validate RPT-QC across a network of four harmonized Sysmex XT-2000iV hematology analyzers and determine the total error that can be controlled with RPT-QC.
A 10-year-old female Golden Retriever was presented for a recheck after the complete removal of low-grade complex mammary carcinoma. The in-house ProCyte Dx automated counts revealed moderate regenerative anemia and moderate eosinophilia. The ProCyte Dx WBC scattergram showed a cloud in an unusual place parallel and to the right of the monocyte dot plot location.
View Article and Find Full Text PDFQuality control validation for a veterinary laboratory network of six Sysmex XT-2000iV hematology analyzers.
Vet Clin Pathol
December 2022
SYNLAB-VPG/Exeter, Unit 1b, Science Park, Exeter, UK.
Background: Quality control (QC) validation is an important step in the laboratory harmonization process. This includes the application of statistical QC requirements, procedures, and control rules to identify and maintain ongoing stable analytical performance. This provides confidence in the production of patient results that are suitable for clinical interpretation across a network of veterinary laboratories.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!